$CYTX Maxim Raises Cytori Price Target As It Gets FDA Conditional Approval For Clinical Trial In Scleroderma http://www.smarteranalyst.com/2014/12/10/maxim-raises-cytori-therapeutics-price-target-as-it-gets-fda-conditional-approval-for-clinical-trial-in-scleroderma/